Join
Live feed
·
INSIDERFilingvia Quantisnow
OptimizeRx Corporation logo

Chief Finance & Strat Officer Stelmakh Edward converted options into 5,237 shares and sold $18,752 worth of shares (1,388 units at $13.51), increasing direct ownership by 3% to 126,830 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPRX (OptimizeRx Corporation) and more on Quantisnow.